Price
No data yet.
Social Signal Score
Analyst Ratings
20 analystsRevenue
$1.54B+16.49%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Denise Dignam
- Sector
- Basic Materials
- Industry
- Chemicals - Specialty
- Employees
- 5,700
- Beta
- 1.46
- Country
- US
- Piotroski score
- 5 / 9 (Middling)
- Altman Z-score
- 1.28
Financials
Revenue
$1.54B+16.5%Net Income
$196.00MEBITDA
$370.00MFree Cash Flow
$98.00M-41.3%EPS (diluted)
$1.29Shares Outstanding (diluted)
151.91M-18.3%Operating Expenses
$-1.00MCash & Debt
$698.00MReturn of Capital
$13.00MRevenue by Segment (annual)
$5.76BDividend per Share
$0.09Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $5.81B | $-386.00M | $-2.57 |
| 2024 | $5.78B | $86.00M | $0.58 |
| 2023 | $6.08B | $-238.00M | $-1.60 |
| 2022 | $6.83B | $578.00M | $3.72 |
| 2021 | $6.34B | $608.00M | $3.69 |
| 2020 | $4.97B | $219.00M | $1.33 |
| 2019 | $5.53B | $-52.00M | $-0.32 |
| 2018 | $6.64B | $995.00M | $5.62 |
| 2017 | $6.18B | $746.00M | $4.04 |
| 2016 | $5.40B | $7.00M | $0.04 |
| 2015 | $5.72B | $-90.00M | $-0.50 |
| 2014 | $6.43B | $400.00M | $2.21 |
| 2013 | $6.86B | $423.00M | $2.33 |
| 2012 | $7.37B | $1.06B | $5.83 |
Valuation
CChas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
50+66.67%Social Signal Score
Mentions (25)
- Newsprnewswire.com·4d ago·Neutral
…e Wellman and Appointment of Amy Rocklin as General Counsel WILMINGTON, Del., Nov. 18, 2026 /PRNewswire/ -- The Chemours Company ("Chemours" or "the Company") (NYSE: CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions ("TSS"), Titanium Technologies ("TT"), and Advanced Performance Materials ("APM"), today announced that Kristine Wellman, Senior Vice President, General Counsel & Corporate Secretary, will retire from Chemours.
View source ↗ - Newszacks.com·17d ago·Negative
CC Launches Faizeon Cooling Solutions to Meet AI Data Center Demand Chemours launches Faizeon two-phase liquid cooling solutions to tackle AI data center heat challenges, offering improved efficiency and reduced water consumption.
View source ↗ - Newsseekingalpha.com·19d ago·Positive
The Chemours Company (CC) Q3 2026 Earnings Call Transcript The Chemours Company ( CC ) Q3 2026 Earnings Call November 3, 2026 8:00 AM EST Company Participants Brandon Ontjes - Vice President of Investor Relations Denise Dignam - President, CEO & Director Shane Hostetter - Senior VP & CFO Conference Call Participants Caleb Boehnlein - BMO Capital Markets Equity Research Peter Osterland - Truist Securities, Inc., Research Division John Ezekiel Roberts - Mizuho Securities USA LLC, Research Division…
View source ↗ - Newsseekingalpha.com·19d ago·Positive
Chemours: Patient Investors Can Be Rewarded (Rating Upgrade) Chemours is upgraded to a buy after a 27% drop, with valuation now compelling and downside risks priced in. CC's EBITDA guidance is trimmed to $775-$785M for 2023, reflecting weaker volumes despite robust pricing and segment margin improvements. Resolution of environmental liabilities within accruals reduces legacy risk, allowing management to focus on future growth opportunities.
View source ↗ - Newszacks.com·20d ago·Negative
Chemours (CC) Misses Q3 Earnings and Revenue Estimates Chemours (CC) came out with quarterly earnings of $0.21 per share, missing the Zacks Consensus Estimate of $0.26 per share. This compares to earnings of $0.2 per share a year ago.
View source ↗ - Newszacks.com·20d ago·Neutral
Here's What Key Metrics Tell Us About Chemours (CC) Q3 Earnings Although the revenue and EPS for Chemours (CC) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
View source ↗ - Newsprnewswire.com·20d ago·Negative
…ing AI heat loads with superior performance and reduced energy and water use WILMINGTON, Del., Nov. 2, 2026 /PRNewswire/ -- The Chemours Company ("Chemours") (NYSE: CC), today launched Faizeon™ two-phase liquid cooling solutions 1, for artificial intelligence (AI), high-performance computing (HPC), and high-density data centers.
View source ↗ - Newsprnewswire.com·20d ago·Neutral
The Chemours Company Reports Third Quarter Results WILMINGTON, Del., Nov. 2, 2026 /PRNewswire/ -- The Chemours Company ("Chemours" or "the Company") (NYSE: CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions ("TSS"), Titanium Technologies ("TT"), and Advanced Performance Materials ("APM"), today announced its financial results for the third quarter 2026.
View source ↗ - News247wallst.com·24d ago·Neutral
DTCC Launched Tokenization on Canton With Ondo as a Partner. Which Coin Benefits More? DTCC just launched a tokenization service backed by Fidelity, JPMorgan, and Bank of America, and both Canton Coin and Ondo landed spots in the rollout.
View source ↗ - Newsprnewswire.com·26d ago·Negative
Chemours Announces Fourth Quarter Dividend WILMINGTON, Del., Oct. 27, 2026 /PRNewswire/ -- The Chemours Company ("Chemours") (NYSE: CC) today announced that the Board of Directors of Chemours declared a quarterly cash dividend of $0.0875 per share on the Company's common stock for the fourth quarter of 2026.
View source ↗ - Newsprnewswire.com·32d ago·Neutral
Chemours Announces Dates for Third Quarter 2026 Earnings Release and Webcast Conference Call WILMINGTON, Del., Oct. 21, 2026 /PRNewswire/ -- The Chemours Company ("Chemours" or "the Company") (NYSE: CC) today announced that the Company expects to issue its third quarter 2026 financial results after market on Monday, November 2, 2026.
View source ↗ - Newsseekingalpha.com·36d ago·Neutral
…ory Is Not Reflective Of The Upside Chemours is rated 'BUY' with a $20 price target and $30 fair value, reflecting significant undervaluation and recovery potential. CC's investment thesis centers on operating leverage, balance sheet repair, and recovery in non-thermal segments, with normalized EPS targeted at $2.5/share. Despite current elevated leverage (4.4x) and declining earnings, CC's debt reduction and EBITDA improvement could drive re-rating and substantial upside by 2027-2028E.
View source ↗ - Newsbenzinga.com·39d ago·Negative
This Chemours Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
View source ↗ - Newsbusinesswire.com·40d ago·Negative
CC Class Action Notice: Chemours Sued for Securities Fraud After Opteon Demand Issues Lead to 18% Stock Drop – Investors Urged to Contact BFA Law by December 7 Deadline NEW YORK--(BUSINESS WIRE)---- $CC #BFA--Chemours Sued for Securities Fraud After Opteon Demand Issues Lead to 18% Stock Drop – Investors Urged to Contact BFA Law by December 7 Deadline.
View source ↗ - Newsbusinesswire.com·42d ago·Neutral
The Chemours Company Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – CC LOS ANGELES--(BUSINESS WIRE)---- $CC--The Chemours Company Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – CC.
View source ↗ - Newsbusinesswire.com·43d ago·Negative
CC Investors Have Opportunity to Lead The Chemours Company Securities Fraud Lawsuit with SBS Law LOS ANGELES--(BUSINESS WIRE)---- $CC--CC Investors Have Opportunity to Lead The Chemours Company Securities Fraud Lawsuit with SBS Law.
View source ↗ - News247wallst.com·54d ago·Neutral
The Dividend Screener Says High Yield. But These Chemical Stocks Tell a Different Story Chemical stocks are flashing some of the highest dividend yields in the sector right now, but the number your screener shows and the check you will actually receive are not the same thing, and the gap between them hides a
View source ↗ - Newsbusinesswire.com·73d ago·Negative
Baron & Budd Secures $380 Million Settlement With DuPont, Chemours, and Corteva Over North Carolina PFAS Contamination DALLAS--(BUSINESS WIRE)--Baron & Budd has secured a $380 million settlement with DuPont, The Chemours Company, and Corteva on behalf of 11 North Carolina public entities to resolve claims arising from PFAS contamination. The entities - Bladen County, Brunswick County, Columbus County, Cumberland County, New Hanover County, Robeson County, Sampson County, Town of Wrightsville Bea
View source ↗ - Newsreuters.com·73d ago·Neutral
Chemours, DuPont, Corteva settle North Carolina 'forever chemicals' claims for $455 million Chemours , DuPont and Corteva on Thursday reached a $455 million settlement with North Carolina and 11 local entities over PFAS contamination claims tied to Chemours' Fayetteville Works plant and other historical discharges.
View source ↗ - Newsprnewswire.com·73d ago·Negative
DuPont, Chemours and Corteva Reach Agreement to Resolve PFAS-Related Claims in North Carolina Resolves litigations brought by the State of North Carolina and 11 local entities relating to PFAS and other historical discharges from Fayetteville Works, as well as the State's claims of PFAS contamination unrelated to that site, including from the use of aqueous film forming foam ("AFFF"). Settlement payments over 15 years, with a net present value of approximately $355 million to be shared by DuPont
View source ↗ - Newsprnewswire.com·73d ago·Negative
Chemours, DuPont and Corteva Reach Agreement to Resolve PFAS-Related Claims in North Carolina Resolves litigations brought by the State of North Carolina and 11 local entities relating to PFAS and other historical discharges from Fayetteville Works, as well as the State's claims of PFAS contamination unrelated to that site, including from the use of aqueous film forming foam ("AFFF"). Overall settlement payments total $455 million over 15 years; Chemours' 50% share of payments of approximately $
View source ↗ - Newsprnewswire.com·89d ago·Negative
Chemours Publishes 2025 Sustainability Report Highlighting Progress on Climate, Emissions Reduction, and Responsible Manufacturing WILMINGTON, Del., Aug. 25, 2026 /PRNewswire/ -- The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions (TSS), Titanium Technologies (TT), and Advanced Performance Materials (APM), today announced the release of its 2025 Sustainability Report.
View source ↗ - Newszacks.com·100d ago·Neutral
Chemours Expands Low-GWP Refrigerant Portfolio for Data Centers CC expands its low-GWP Opteon refrigerant portfolio to meet rising cooling needs from AI-driven data centers and support decarbonization goals.
View source ↗ - Newszacks.com·103d ago·Negative
Chemours' Q2 Earnings & Revenues Lag Estimates on Lower Volumes CC's Q2 loss narrows, but lower volumes and sales weigh on results as it outlines a cautious Q3 outlook.
View source ↗ - Newsprnewswire.com·104d ago·Negative
Chemours Launches Opteon™ ZE and Opteon™ 515B Refrigerants for Chiller Applications Powering Data Centers, Commercial Buildings, and Other Mission Critical Environments New additions to the Opteon™ portfolio support high-performance, sustainable cooling solutions in stationary chillers for AI-driven data centers, and commercial HVAC applications WILMINGTON, Del., Aug. 10, 2026 /PRNewswire/ -- The Chemours Company (Chemours) (NYSE: CC), a global chemistry company, today announced the launch of Op
View source ↗
Earnings
Thu, Feb 18(in 3 months)
Consensus estimate $0.12 per share
Typical surprise -16.7% (median, so one quarter with a near-zero estimate can't distort it)
- Mon, Nov 2$0.21 vs $0.27miss
- Tue, Aug 4$0.42 vs $0.49miss
- Tue, May 5$0.05 vs $-0.05beat
- Thu, Feb 19$0.05 vs $0.09miss
- Thu, Nov 6$0.20 vs $0.24miss
- Tue, Aug 5$0.58 vs $0.46beat
Estimates and results for CC via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by CC officers and directors.
- Bought
- $789k
- Sold
- —
11 trades
0 trades
- Familiar Calderon Gerardobought
- Dignam Denisebought
- Cowan Alisterbought
- Foley Michael Robertbought
- Cranston Mary Bbought
- Martinko Joseph T.bought
- Hostetter Shanebought
- Dignam Denisebought
89 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Prediction Markets
Live market-implied probabilities from Polymarket. These are odds traders are paying for, not forecasts — and not investment advice.
- Salesforce Q3 current RPO growth (CC)?$12K vol · resolves Dec 2, 2026
- Will Salesforce Q3 current RPO growth (CC) be between 16% and 17%?34%
- Will Salesforce Q3 current RPO growth (CC) be between 15% and 16%?27%
- Will Salesforce Q3 current RPO growth (CC) be above 17%?18%
- Will Salesforce Q3 current RPO growth (CC) be between 14% and 15%?16%
- Will Salesforce Q3 current RPO growth (CC) be between 13% and 14%?10%
Congress trades
- Ro Khannahouse · CA17 · disclosed Feb 5, 2024 (26d later)Sell$1,001 - $15,000
- Michael C. Burgesshouse · TX26 · disclosed Sep 5, 2023 (27d later)Buy$15,001 - $50,000
- Michael C. Burgesshouse · TX26 · disclosed Jul 18, 2023 (12d later)Sell$1,001 - $15,000
- Michael C. Burgesshouse · TX26 · disclosed Jul 18, 2023 (12d later)Buy$15,001 - $50,000
- Ro Khannahouse · CA17 · disclosed Dec 6, 2022 (33d later)Buy$1,001 - $15,000
- Tammy Duckworthsenate · IL · disclosed Nov 7, 2017 (28d later)Sell$1,001 - $15,000
Self-reported filings, amounts as brackets. Via Senate/House disclosures.
